AN2 Therapeutics’ $70 Million Common Stock Offering

Leila Ahmed North America Legal Chronicle
Tagged:

Cooley advised AN2 Therapeutics, Inc., and Davis Polk & Wardwell advised the joint book-running managers on the offering.AN2 Therapeutics, Inc. (Nasdaq:ANTX) announced a SEC-registered follow-on offering…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here